Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-1219
Vascular graft market is poised to value over USD 5.1 billion by 2028 end at a CAGR of over 7.3% during the forecast period 2022 to 2028. Increasing cases of vascular disorders, hypertension, and high blood sugar are driving the growth of the market. Technological advancements and increase in geriatric population are expected to bolster the market over the forecast period. Cardiovascular diseases are one of the most common causes of heart attack. According to the figures released by American Heart Association in 2018, 720,000 people suffered heart attack and the prevalence of myocardial infarction was approximately 7.8 million. The high prevalence of cardiovascular diseases is also estimated to increase the global vascular graft market size. The market is bifurcated into by product, by application, by raw material, and by region. In terms of product, endovascular stent grafts are expected to control the vascular graft market growth. The growing prevalence of cardiovascular aneurysms due to unhealthy eating habits and sedentary lifestyle remains the major promoting the growth of endovascular stent-grafts. Technological advancements such as Fortevo and Nellix is expected to positively influence the market. Peripheral vascular grafts are also expected to show considerable growth owing to improvements and advancements made related to development of intra-operative techniques. On the basis of application, cardiac aneurysms are expected to control the growth of the market. High prevalence of blood pressure and increasing adoption of novel prosthetic grafts is anticipated to drive the demand of cardiac aneurysms segment thus inflating the vascular graft market share. Adoption of unhealthy lifestyle habits and rising geriatric population is also anticipated to spike the growth of the market. Based on raw materials, PTFE is expected to show notable growth. PTFE is designed with technically-advanced structure which yields minimal blood loss and delivers utmost protection from delamination. It can also opt for peripheral bypasses. Owing to these factors, there has been a demand for PTFE which is positively influencing the market. Biological materials are also expected to hold vast segment of the market due to the reduction in demand for polymer grafts and increasing prevalence of cardiovascular diseases. On the basis of region, North America dictates the growth of the market. Increasing geriatric population and the high prevalence of diabetes is fueling the growth of the market in the region. Increasing the incidence of chronic kidney disease coupled with presence of favorable reimbursement policy in the region is proliferating the vascular graft market size. Europe is estimated to be a lucrative region owing to the growing number of projects funded by the European Union on biomaterials research. The rise in cardiovascular disease cases is also propelling the market in the region. According to figures released by British Heart Foundation, approximately 2.3 million people in UK suffered from coronary heart disease. The increasing prevalence of cardiovascular diseases is expected to drive the growth of the market in the region. Key Market Players are Cardinal Health Inc, LeMaitre Vascular, Inc., Medtronic plc, W.L Gore & Associates, Inc., Jotec GmbH, Nano Endoluminal, Lombard Medical,Inc., Cardiatis S.A, B.Braun Melsungen AG, and Endologix Inc, Cook Medical. Vascular Graft Market Segmentation: By Raw Material Polyester Grafts ePTFE Polyurethane Grafts Biosynthetic Grafts By Indication Endovascular Aneurysm Repair o Abdominal Aortic Aneurysms Repair o Thoracic Aortic Aneurysm Repair Peripheral Vascular Hemodialysis Access By End User Hospitals Ambulatory Surgical Centers By Region North America Europe Asia Pacific Latin America Middle East and Africa Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Growth Prospects SWOT Analysis Key Trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the vascular graft market by raw material, by indication, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, industry-specific restraints and opportunities) To forecast and evaluate micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record, evaluate and analyse competitive landscape mapping- technological advancements, product launches, expansions and mergers Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Increasing cases of vascular disorders, hypertension, and high blood sugar are driving the growth of the market. Technological advancements and increase in geriatric population are expected to bolster the market over the forecast period. Cardiovascular diseases are one of the most common causes of heart attack. According to the figures released by American Heart Association in 2018, 720,000 people suffered heart attack and the prevalence of myocardial infarction was approximately 7.8 million. The high prevalence of cardiovascular diseases is also estimated to increase the global vascular graft market size.
The market is bifurcated into by product, by application, by raw material, and by region. In terms of product, endovascular stent grafts are expected to control the vascular graft market growth. The growing prevalence of cardiovascular aneurysms due to unhealthy eating habits and sedentary lifestyle remains the major promoting the growth of endovascular stent-grafts. Technological advancements such as Fortevo and Nellix is expected to positively influence the market.
Peripheral vascular grafts are also expected to show considerable growth owing to improvements and advancements made related to development of intra-operative techniques.
On the basis of application, cardiac aneurysms are expected to control the growth of the market. High prevalence of blood pressure and increasing adoption of novel prosthetic grafts is anticipated to drive the demand of cardiac aneurysms segment thus inflating the vascular graft market share. Adoption of unhealthy lifestyle habits and rising geriatric population is also anticipated to spike the growth of the market.
Based on raw materials, PTFE is expected to show notable growth. PTFE is designed with technically-advanced structure which yields minimal blood loss and delivers utmost protection from delamination. It can also opt for peripheral bypasses. Owing to these factors, there has been a demand for PTFE which is positively influencing the market.
Biological materials are also expected to hold vast segment of the market due to the reduction in demand for polymer grafts and increasing prevalence of cardiovascular diseases.
On the basis of region, North America dictates the growth of the market. Increasing geriatric population and the high prevalence of diabetes is fueling the growth of the market in the region. Increasing the incidence of chronic kidney disease coupled with presence of favorable reimbursement policy in the region is proliferating the vascular graft market size.
Europe is estimated to be a lucrative region owing to the growing number of projects funded by the European Union on biomaterials research. The rise in cardiovascular disease cases is also propelling the market in the region. According to figures released by British Heart Foundation, approximately 2.3 million people in UK suffered from coronary heart disease. The increasing prevalence of cardiovascular diseases is expected to drive the growth of the market in the region.
Key Market Players are Cardinal Health Inc, LeMaitre Vascular, Inc., Medtronic plc, W.L Gore & Associates, Inc., Jotec GmbH, Nano Endoluminal, Lombard Medical,Inc., Cardiatis S.A, B.Braun Melsungen AG, and Endologix Inc, Cook Medical.
Vascular Graft Market Segmentation: By Raw Material
By Indication
By End User
By Region
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Vascular Graft Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Vascular Graft Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Vascular Graft Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Vascular Graft Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Vascular Graft Market, By Raw Material Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Polyester Grafts 7.2. ePTFE 7.3. Polyurethane Grafts 7.4. Biosynthetic Grafts 8. Global Vascular Graft Market, By Indication Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Endovascular Aneurysm Repair 8.1.1. Abdominal Aortic Aneurysms Repair 8.1.2. Thoracic Aortic Aneurysm Repair 8.2. Peripheral Vascular 8.3. Hemodialysis Access 9. Global Vascular Graft Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospitals 9.2. Ambulatory Surgical Centers 10. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Cardinal Health Inc 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. LeMaitre Vascular, Inc.. 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Medtronic plc. 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. W.L Gore & Associates, Inc. 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Jotec GmbH 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Nano Endoluminal 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Lombard Medical,Inc. 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Cardiatis S.A 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. B.Braun Melsungen AG 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Endologix Inc. 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11. Cook Medical 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics